// App-Quantinova.ai

84 P-2-265 : Importance of Thrombocyte Volume Parameters in Type 1 Diabetes Mellitus Patients with and without Clinical Findings of Diabetic Ketoacidosis

Researchers

Presenter

  • Dogus Vuralli

Principal Investigators

  • Hatice Tatar Aksoy

  • Arzu Yilmaz

  • Ozlem Engiz

  • Yildiz Bilge Dallar

Medical Centers

  • Ankara Research and Training Hospital, Ankara, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 1 diabetes mellitus

  • Diabetic ketoacidosis

  • Diabetes

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved